Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Liabilities and Shareholders Equity: 2022-2024

Historic Liabilities and Shareholders Equity for NewGenIvf (NIVF) over the last 3 years, with FY2024 value amounting to $3.6 million.

  • NewGenIvf's Liabilities and Shareholders Equity changed N/A to $35558.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $35558.4 billion, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 2026.42% down from last year.
  • According to the latest figures from FY2024, NewGenIvf's Liabilities and Shareholders Equity is $3.6 million, which was down 2026.42% from $4.5 million recorded in FY2023.
  • NewGenIvf's Liabilities and Shareholders Equity's 5-year high stood at $4.5 million during FY2023, with a 5-year trough of $2.9 million in FY2022.
  • Its 3-year average for Liabilities and Shareholders Equity is $3.7 million, with a median of $3.6 million in 2024.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 5445.95% in 2023, then tumbled by 2026.42% in 2024.
  • NewGenIvf's Liabilities and Shareholders Equity (Annual) stood at $2.9 million in 2022, then surged by 54.46% to $4.5 million in 2023, then dropped by 20.26% to $3.6 million in 2024.
  • Its Liabilities and Shareholders Equity stands at $3.6 million for FY2024, versus $4.5 million for FY2023 and $2.9 million for FY2022.